NeuroSense Therapeutics Ltd. Warrant (NRSNW) Debt by Year
NeuroSense Therapeutics Ltd. Warrant held $166K in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters NeuroSense Therapeutics Ltd. Warrant has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NRSNW Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
NRSNW Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More NeuroSense Therapeutics Ltd. Warrant financials
Frequently Asked Questions
What was NeuroSense Therapeutics Ltd. Warrant's long-term debt in fiscal year 2025?
NeuroSense Therapeutics Ltd. Warrant held $166K in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what NeuroSense Therapeutics Ltd. Warrant (NRSNW) reported on that line in every period on record.